The main department of described VC is located in the Cambridge. The company was established in Europe in United Kingdom.
The usual things for fund are deals in the range of 1 - 5 millions dollars. The higher amount of exits for fund were in 2013. The fund is generally included in less than 2 deals every year. The high activity for fund was in 2001.
We can highlight the next thriving fund investment areas, such as Health Care, Biotechnology. Moreover, a startup needs to be at the age of 1 and less years to get the investment from the fund. Among the most popular portfolio startups of the fund, we may highlight Spirogen. For fund there is a match between the location of its establishment and the land of its numerous investments - United Kingdom.
The typical case for the fund is to invest in rounds with 1-2 participants. The meaningful sponsors for the fund in investment in the same round are Sitka Partners. In the next rounds fund is usually obtained by Auven Therapeutics.
Related Funds
Funds with similar focus
Fund Name | Location |
11k Ventures | Germany, Hamburg |
Avenue Venture | India, Maharashtra, Mumbai |
Ballmer Group | Bellevue, United States, Washington |
BG Media | New York, New York, United States |
C.E. Unterberg, Towbin | New York, New York, United States |
Flynn & Gallagher Investments | - |
Foyer | Canton Esch-sur-Alzette, Leudelange, Luxembourg |
Gaoling Investment Management | China, Hangzhou, Zhejiang |
Government of the Republic of Rwanda | - |
KingSett Capital | Canada, Ontario, Toronto |
Live Nation Labs | Beverly Hills, California, United States |
Marlin Equity Partners | California, Hermosa Beach, United States |
MI Investment Holding | - |
Rabo Foundation | Netherlands, Utrecht, Utrecht |
Repair Impact Fund | Denmark, Hellerup, Hovedstaden |
Rhythm VC | New York, New York, United States |
Tellhow | China, Futian, Guangdong |
TrustBIX | Alberta, Canada, Edmonton |
TWB Investment | Seattle, United States, Washington |
Zolon Ventures | Andhra Pradesh, Hyderabad, India |
Notable deals
Company | Industry | Round Size | Date | Investors | Location |
Phico Therapeutics | $616K | 01 Feb 2003 | Cambridge, England, United Kingdom | ||
Spirogen | $1M | 28 Mar 2001 | London, England, United Kingdom | ||
Phico Therapeutics | 01 Sep 2000 | Cambridge, England, United Kingdom |
1. You post comments at your own choice and risk. You bear the whole responsibility,related to their substance, content and the fact of publication. We shall not bear anyliability in respect of such comments.
2. While commenting, you shall use only actual, truthful and confirmed data. In thesame time you shall not use vulgar, abusive or defamatory language as well as expresshatred or call to violence or cruelty.
3. We do not intend to delete any comments on the website unless within our “noticeand take down” procedure.
4. We can moderate comments at any time.
5. While commenting, you are under the rule of our website’s terms of use and privacypolicy.
6. We retain our right to delete any comment or any other content of the website at ourwill in case we know or suppose such content is illegal or breaches any lawful right.
Review
- No reviews are submitted yet.
Sign up and get access to full fund profile and advanced analysis.
Latest deals
Company | Industry | Round Size | Date | Investors | Location |
Phico Therapeutics | $616K | 01 Feb 2003 | Cambridge, England, United Kingdom | ||
Spirogen | $1M | 28 Mar 2001 | London, England, United Kingdom | ||
Phico Therapeutics | 01 Sep 2000 | Cambridge, England, United Kingdom |